Global Lab Automation in Bioanalysis Market Size study & Forecast, by Offering (Equipment, Software), by Type of Analyzers (Biochemistry Analyzers, Immuno-Based Analyzers, Hematology Analyzers, Cell Counters, Coagulometers), and Regional Analysis, 2023-20

Global Lab Automation in Bioanalysis Market Size study & Forecast, by Offering (Equipment, Software), by Type of Analyzers (Biochemistry Analyzers, Immuno-Based Analyzers, Hematology Analyzers, Cell Counters, Coagulometers), and Regional Analysis, 2023-2030

Global Lab Automation in Bioanalysis Market is valued at approximately USD XXX billion in 2022 and is anticipated to grow with a healthy growth rate of more than 6.1% over the forecast period 2023-2030. Lab Automation in Bioanalysis Market refers to the industry involved in the implementation of automated systems and technologies for streamlining and optimizing bioanalysis processes in laboratory settings. This includes the use of robotics, software, and advanced instrumentation to automate sample handling, data analysis, and other laboratory workflows, enhancing efficiency, accuracy, and productivity in bioanalytical testing and research. The Lab Automation in Bioanalysis Market is being driven by factors such as increasing research and development of lab automation technology and rising demand for personalized medicines.

The need to enhance laboratory capabilities worldwide is anticipated to grow in response to the increased focus on research and development Lab automation systems play a pivotal role in meeting the demands of a growing number of clinical trials. These systems can streamline the sample preparation, analysis, and data management processes, reducing human error and ensuring consistency in results. Automation not only accelerates the pace of trials but also enhances the precision and reliability of the data generated, which is crucial in regulatory submissions and decision-making. As according to, ClinalTrials.gov reported a total of 409,300 registered clinical studies as of March 2022. Along with this market vendors are strategically investing in research and development and introducing new products. In March 2022, Mindray launched the BC-700 Series, a hematology analyzer series that combines ESR tests and CBC. It includes autoloader and open vial models, empowering medium-volume laboratories with advanced technologies. Thus, increasing research and development in lab automation technology and increasing investment in introducing new products fueling the market growth. In addition to cost savings & resource optimization and growing demand for high-throughput analysis creates lucrative opportunities for the market. However, the high capital requirements for setup hinder market growth throughout the forecast period of 2023-2030.

The key regions considered for the Global Lab Automation in Bioanalysis Market study includes Asia Pacific, North America, Europe, Latin America, and Middle East & Africa. North America dominated the market in 2022 owing to the well-developed healthcare infrastructure with advanced laboratory facilities and a strong emphasis on research and development and the region is at the forefront of adopting innovative technologies and implementing automated systems for bioanalytical processes. Asia Pacific is considered the fastest growing as fastest growing over the forecast period due to the region has witnessed a significant increase in healthcare expenditure, driven by factors such as population growth, rising disposable income, and increasing awareness of healthcare services.

Major market player included in this report are:
Thermo Fisher Scientific Inc.
Agilent Technologies Inc
Hamilton Company
Siemens Healthineers AG
Becton Dickinson & Co.
Hudson Robotics Inc.
Beckman Coulter Inc. (Danaher Corporation)
Tecan Genomics Inc.
Shimadzu Corporation
PerkinElmer, Inc.

Recent Developments in the Market:
 In May 2023, Thermo Fisher Scientific launched the Automated Indiko Clinical Chemistry analyzer, a state-of-the-art solution designed to deliver rapid and sample-oriented testing results in the field of clinical chemistry. This advanced analyzer is capable of operating with low sample volumes, ensuring efficient utilization of resources. Additionally, it incorporates a water-saving feature, allowing laboratories to run more cost-effectively by reducing water consumption. The introduction of the Automated Indiko Clinical Chemistry analyzer by Thermo Fisher Scientific enhances laboratory productivity and offers a more economical approach to clinical chemistry testing.
 In February 2021, Beckman Coulter unveiled the DxH 560 AL, a compact hematology analyzer specifically developed to address time and resource limitations encountered by small- to mid-sized laboratories. This advanced tabletop analyzer offers auto-loading functionality, closed tube aspiration, and walk-away capabilities, allowing users to conveniently add up to 50 samples continuously. By providing safety against blood-borne pathogens and reducing the need for manual instrument tasks, the DxH 560 AL streamlines workflow efficiency and saves valuable time for laboratory personnel. Overall, the introduction of this analyzer by Beckman Coulter caters to the unique needs of smaller laboratories, enhancing their hematology analysis capabilities.

Global Lab Automation in Bioanalysis Market Report Scope:
 Historical Data – 2020 - 2021
 Base Year for Estimation – 2022
 Forecast period - 2023-2030
 Report Coverage - Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
 Segments Covered - Offering, Type of Analyzers, Region
 Regional Scope - North America; Europe; Asia Pacific; Latin America; Middle East & Africa

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.

The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Offering:
Equipment
Software

By Type of Analyzers:
Biochemistry Analyzers
Immuno-Based Analyzers
Hematology Analyzers
Cell Counters
Coagulometers

By Region:

North America
U.S.
Canada

Europe
UK
Germany
France
Spain
Italy
ROE

Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC

Latin America
Brazil
Mexico

Middle East & Africa
Saudi Arabia
South Africa
Rest of Middle East & Africa

Companies Mentioned
Thermo Fisher Scientific Inc.
Agilent Technologies Inc
Hamilton Company
Siemens Healthineers AG
Becton Dickinson & Co.
Hudson Robotics Inc.
Beckman Coulter Inc. (Danaher Corporation)
Tecan Genomics Inc.
Shimadzu Corporation
PerkinElmer, Inc.

Please note:The single user license is non-downloadable and non-printable. Global Site license allows these actions.